Home/Filings/4/0001415889-22-005567
4//SEC Filing

Duncan Gregory Scott 4

Accession 0001415889-22-005567

CIK 0001818844other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 10:24 AM ET

Size

4.5 KB

Accession

0001415889-22-005567

Insider Transaction Report

Form 4
Period: 2022-05-23
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Purchase

    Common Stock

    2022-05-23$4.52/sh+7,500$33,90032,461 total

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1
  • filerCIK 0001831127

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 10:24 AM ET
Size
4.5 KB